Both the TAVR and TMVR procedures are for patients who are too high risk to undergo open heart surgery. The Oklahoma Heart Institute Team will conduct a comprehensive evaluation to determine whether one of these procedures is an appropriate therapeutic option. For those who are candidates, TAVR or TMVR may improve survival (make you live longer) and provide relief from the often debilitating symptoms associated with severe aortic stenosis and severe mitral regurgitation.
The current ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease recommend surgical aortic valve replacement (SAVR) for virtually all patients with severe, symptomatic aortic stenosis. Without replacement of the aortic valve, this disease is life-threatening and previous studies have shown that 50% of patients will not survive more than an average of two years after the onset of symptoms. While open-heart aortic valve replacement surgery is the gold standard treatment for severe symptomatic aortic valve stenosis, there are patients who are not candidates for open-chest surgery. These inoperable patients may be unable to undergo traditional surgery because of factors such as age, history of heart disease, frailty or other health issues. For these patients, TAVR may be an option.